Trademark: 79326849
Word
LARBIZEL
Status
Registered
Status Code
700
Status Date
Tuesday, May 31, 2022
Serial Number
79326849
Registration Number
6741809
Registration Date
Tuesday, May 31, 2022
Mark Type
4000
Filing Date
Friday, October 8, 2021
Published for Opposition
Tuesday, March 15, 2022

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
In the statement, the filing date has been corrected per the Restriction dated 12/23/2021, and per the Fnote dated08/16/2021.

Trademark Events
Sep 19, 2022
Notification Processed By Ib
Aug 30, 2022
Correction From Ib Entered - No Review Required
Aug 25, 2022
Final Disposition Notice Sent To Ib
Aug 25, 2022
Final Disposition Processed
Aug 21, 2022
Correction Under Section 7 ¿ Processed
Aug 21, 2022
Assigned To Paralegal
Jun 30, 2022
Grant Of Protection Created, To Be Sent To Ib
May 31, 2022
Notice Of Registration Confirmation Emailed
May 31, 2022
Registered-Principal Register
Mar 21, 2022
Notification Processed By Ib
Mar 15, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 15, 2022
Published For Opposition
Feb 23, 2022
Notification Of Possible Opposition Sent To Ib
Feb 23, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 23, 2022
Notification Of Notice Of Publication E-Mailed
Feb 7, 2022
Approved For Pub - Principal Register
Jan 29, 2022
Assigned To Examiner
Jan 26, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 26, 2022
Teas Change Of Correspondence Received
Jan 26, 2022
Teas Change Of Domestic Representatives Address
Jan 26, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 26, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 26, 2022
Teas Change Of Owner Address Received
Dec 25, 2021
Correction Transaction Received From Ib
Dec 17, 2021
Application Filing Receipt Mailed
Dec 13, 2021
New Application Office Supplied Data Entered In Tram
Dec 9, 2021
Limitation From Original Application Entered
Nov 25, 2021
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24